We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$53.7B
AUM Growth
-$2.95B
Cap. Flow
+$168M
Cap. Flow %
0.31%
Top 10 Hldgs %
35.03%
Holding
1,742
New
57
Increased
475
Reduced
481
Closed
34

Sector Composition

Rank Sector Weight
1 Technology 31.44%
2 Financials 12.06%
3 Healthcare 11.81%
4 Communication Services 9.87%
5 Consumer Discretionary 9.04%

No holdings matched the selected filter criteria.

Similar funds

Ensign Peak Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Ensign Peak Advisors held 1,742 positions worth $53.7B, down 5.2% from $56.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors's Q1 2026 filing shows 57 new, 475 increased, 481 reduced and 34 closed positions. Its largest new stake was Novo Nordisk: 400,384 shares worth $14.7M. The largest sale was FTAI Aviation, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

  • Ensign Peak Advisors's largest Q1 2026 buy was Novo Nordisk: 400,384 shares worth $14.7M.
  • Ensign Peak Advisors added most to Boston Scientific in Q1 2026, an estimated $234M increase.
  • Ensign Peak Advisors's biggest Q1 2026 reduction was FTAI Aviation, cutting an estimated $421M.
  • Ensign Peak Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $17M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $53.7B portfolio in Q1 2026.
  • Ensign Peak Advisors opened 57 new positions and closed 34 in Q1 2026.
  • Ensign Peak Advisors's portfolio value fell 5.2% quarter-over-quarter to $53.7B.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.